City of Hope, founded in 1913 and based in Duarte, California, is a prominent nonprofit cancer research and treatment center dedicated to transforming the lives of patients facing serious illnesses. The organization is renowned for its cutting-edge research, compassionate patient care, and commitment to advancing treatment modalities including immunotherapy and personalized medicine.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| HOPECA 4.38% 2048-08-15 USDCity of Hope | United States | 2048-08-15 | 4.378 | 5.68 |
| HOPECA 5.62% 2043-11-15 USDCity of Hope | United States | 2043-11-15 | 5.623 | 5.63 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
City of Hope began issuing bonds in the early 2000s to finance facility expansions and support research initiatives. Notably, its recent bond issuance in 2020 raised $500 million to enhance clinical care and research infrastructure, achieving competitive yields that align favorably with industry standards. The bonds offer unique features such as tax-exempt status, appealing to a range of institutional investors. As of late 2023, City of Hope's bond ratings remain strong, reflecting the institution's robust financial health and commitment to advancing medical innovation.